Platforms - ELISpot Solutions
Enzyme-linked immunosorbent spot (ELISpot) is a highly flexible assay and can be adapted to multiple readout formats. ELISpot assays are quantitative and measure key cellular functions of immune system cells. ELISpot has been used to assess both adaptive and innate immune responses, and KCAS has expertise in offering ELISpot support with your pharmacodynamic markers.
KCAS has expanded to offer you expertise in Elispot technology
The Ligand Binding Assay (LBA) team at KCAS is growing to meet the changes in bioanalytical support of biopharmaceuticals and biomarker testing. The footprint of our LBA laboratory has doubled in the new space to accommodate many more scientists, additional instrumentation, and all-new equipment. Whether you are working on cell therapies, gene therapies, or a combination of cell and gene therapies KCAS has you covered
KCAS ELISpot Services
Methods transferred into a new laboratory need to be re-established for regulatory compliance….
Cell based assays are highly specialized in vitro methods that can evaluate the functional and…
At KCAS, methods are developed with a fit-for-purpose design in mind, based on our Client’s ne…
A fit-for-purpose approach is used by KCAS in method qualifications. Each method is designed t…
KCAS has extensive experience in validating methods in a wide range of bioanalytical platforms…
Regulated clinical bioanalysis is a key focus at KCAS, supporting both human and animal health…
Non-clinical (or often referred to as preclinical studies) non GLP samples are often used for…
The discovery phase in drug development requires rapid and reliable data in making key decisio…
PD Analysis is the assistance with design, regulatory requirements and final data interpretati…
The extent to which a drug binds to plasma proteins can range from neglible to 99.9+% with com…
Tissue bioanalysis is an essential area in understanding the extent of drug distribution, meta…